Intelligent Medicine Acquisition Corp.
IQMDU
NASDAQ Global Market10.98
USD
+0.49
- -
Intelligent Medicine Acquisition Corp.
IQMDU
(NASDAQ Global Market)
Recent
price
10.98
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Intelligent Medicine Acquisition Corp. (IQMDU) operates as a blank check company whose principal business activity focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses, particularly targeting life science companies leveraging artificial intelligence, machine learning, and big data to advance drug discovery and development; it offers no current products or services beyond its SPAC structure. The company, founded in 2021 and headquartered at 9001 Burdette Road in Bethesda, Maryland, United States, conducts operations primarily in the United States within the diversified financials sector, specifically shell companies and investment holding. In April 2023, Intelligent Medicine Acquisition Corp. announced its intention to dissolve and liquidate after failing to consummate an initial business combination within the required timeframe under its charter, redeeming all outstanding Class A common shares included in its initial public offering units at approximately $11.22 per share based on trust account funds as of April 24, 2023; trading of its shares ceased on Nasdaq on April 27, 2023, with subsequent delisting via Form 25 and termination of SEC registration via Form 15, while warrants expired worthless and sponsor shares waived redemption rights.